StockData
Clearmind Medicine Inc. logo

Clearmind Medicine Inc. (CMND) stock

CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Score 5/30
$3.45−0.73 (-17.52%)

Close on Nov 17, 2026Market cap $545.36KP/E –Yield –

Clearmind Medicine operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2023CQ1 2023Apr 30, 2023-$1.66M–
Q2 FY2022CQ1 2022Apr 30, 2022-$2.22M–

More Clearmind Medicine figures

See a number that looks wrong?